Test Code TOBT TOBRAMYCIN, TROUGH
Methodology
Homogeneous Enzyme Immunoassay
Useful For
Monitoring adequacy of clearance of tobramycin near the end of a dosing cycle.
Tobramycin is an antibiotic used to treat life-threatening blood infections by gram-negative bacilli, particularly Citrobacter freundii, Enterobacter (all species), Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Providencia stuartii, Pseudomonas aeruginosa, and Serratia species. It is often used in combination with beta-lactam therapy.
A tobramycin minimum inhibitory concentration (MIC) of less than 4.0 mcg/mL is considered susceptible for gram-negative bacilli, while a MIC of greater than 8.0 mcg/mL is considered resistant.
Ototoxicity and nephrotoxicity are the primary toxicities associated with tobramycin. This risk is enhanced in presence of other ototoxic or nephrotoxic drugs. Monitoring of serum levels and symptoms consistent with ototoxicity is important. For longer durations of use, audiology/vestibular testing should be considered at baseline and periodically during therapy.
Specimen Requirements
Preferred:
Specimen Type: Serum
Container/Tube: Serum Gel Tube
Specimen Volume: 0.5 mL serum (minimum 0.25 mL)
Alternate: Serum, Plain red-top tube
Heparin Plasma, Green top gel tube
Collection Instructions:
- Draw no more than 30 minutes before next schedule dose.
- Spin down within 1 hour of draw.
- Store specimens refrigerated until assayed.
Day(s) Test Set Up
Monday through Sunday
Specimen Stability
Refrigerated
Reference Values
Conventional dosing: < 2.0 mcg/mL
High-dose extended interval dosing: < 1.0 mcg/mL
Critical Level: > 2.0 mcg/mL
Performing Laboratory
Logan Health Medical Center Laboratory
Test Classification and CPT Coding
80200